rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-1
|
pubmed:abstractText |
Several reports found that obesity was associated with prostate cancer (PC) aggressiveness among men treated with radical prostatectomy or radiotherapy. Studies concerning this issue have basically relied on body mass index (BMI), as a marker for general obesity. Because visceral fat is the most metabolic active fat, we sought to evaluate if periprostatic fat measured on a computed tomography (CT) is a better marker than BMI to predict PC aggressiveness in a Dutch population who underwent brachytherapy for localized PC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1433-8726
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
699-704
|
pubmed:meshHeading |
pubmed-meshheading:20033185-Adipose Tissue,
pubmed-meshheading:20033185-Aged,
pubmed-meshheading:20033185-Aged, 80 and over,
pubmed-meshheading:20033185-Body Fat Distribution,
pubmed-meshheading:20033185-Body Mass Index,
pubmed-meshheading:20033185-Brachytherapy,
pubmed-meshheading:20033185-Disease Progression,
pubmed-meshheading:20033185-Humans,
pubmed-meshheading:20033185-Male,
pubmed-meshheading:20033185-Middle Aged,
pubmed-meshheading:20033185-Prostatic Neoplasms,
pubmed-meshheading:20033185-Retrospective Studies,
pubmed-meshheading:20033185-Tomography, X-Ray Computed,
pubmed-meshheading:20033185-Treatment Outcome,
pubmed-meshheading:20033185-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness.
|
pubmed:affiliation |
Department of Urology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. j.g.h.vanroermund@umcutrecht.nl
|
pubmed:publicationType |
Journal Article,
Comparative Study
|